An autoradiographic study of the distribution of binding sites for the novel α7‐selective nicotinic radioligand [3H]‐methyllycaconitine in the mouse brain
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
[3 H]‐Methyllycaconitine ([3 H]‐MLA) is a new radioligand with selectivity for α7‐type neuronal nicotinic acetylcholine receptors (nAChRs). In our previous study [Davies, A.R.L., Hardick, D.J., Blagbrough, I.S., Potter, B.V.L., Wolstenholme, A.J. & Wonnacott, S. (1999) Neuropharmacology, 38, 679–690], this radioligand labelled a single class of site in rat brain membranes; its pharmacology and distribution in crudely dissected brain regions closely paralleled that of the well‐established α7‐ligand [125 I]‐α‐bungarotoxin. However, a small population of [3 H]‐MLA binding sites was apparently insensitive to α‐bungarotoxin. Here we have extended the study to mouse brain, using autoradiography to examine the distribution of [3 H]‐MLA and [125 I]‐α‐bungarotoxin binding sites. [3 H]‐MLA labelled a single class of site in mouse brain membranes with a K D of 2.2 n m and a B max of 45.6 fmol/mg protein. Specific binding, defined by unlabelled MLA (K i = 0.69 n m), was completely inhibited by (–)‐nicotine (K i = 1.62 μ m), whereas α‐bungarotoxin inhibited only 85% of specific binding (K i = 3.5 n m). The distributions of [125 I]‐α‐bungarotoxin and [3 H]‐MLA binding sites were compared by autoradiography, and binding was quantitated in 72 brain regions. Binding of both radioligands was highly correlated, with highest densities in the dorsal tegmental nucleus of the pons, colliculi and hippocampus. Serial sections labelled with [3 H]‐MLA in the absence or presence of unlabelled MLA or α‐bungarotoxin provided no evidence for any α‐bungarotoxin‐resistant binding. The results are discussed in terms of binding sites that are inaccessible to α‐bungarotoxin in membrane preparations. This study demonstrates the utility of [3 H]‐MLA for characterization of α7‐type nicotinic receptors in mammalian brain, and suggests that it labels a population identical to that defined by [125 I]‐α‐bungarotoxin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762 · cited 1×
“They display very high Ca2+ permeability, rapid desensitization, are abundant in hippocampus and appear early in development (Role & Berg, 1996; Albuquerque et al., 1997).”
BackgroundNicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Self-citationPauly, J. R., Marks, M. J., Gross, S. D., & Collins, A. C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20464-5 · Cited by 152 · cited 1×
“Comparison of speci®c binding levels (Table 2) with previous [125I]-a-Bgt autoradiography studies in mouse brain (Pauly et al., 1989, 1991) con®rms that the pattern of binding is the same.”
MethodSelf-citation
Cited by
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“Another nicotinic subunit that contributes to the somatic signs of withdrawal is the α2 subunit (Salas et al. 2009), which is selectively expressed in rodent IPN and olfactory bulb (Ishii et al. 2005, Whiteaker et al. 1999).”
BackgroundNicotinic receptor subtypes and cognitive function
Levin, E. D. (2002) · Journal of Neurobiology · doi:10.1002/neu.10151 · Cited by 354
Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine
Kenney, J. W., & Gould, T. J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8037-9 · Cited by 242
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233
“The affinity (KD) and binding site density (Bmax) of [ H]-MLA in WT mice was consistent with previous studies in mice (Whiteaker et al., 1999) and rats (Davies et al.”
ResultDajas-Bailador, F. A., Lima, P. A., & Wonnacott, S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00127-1 · Cited by 180
Self-citation
Metadata
- Authors
- Whiteaker, P., Davies, A. R. L., Marks, M. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., Collins, A. C., & Wonnacott, S.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 1999-08
- Volume
- 11
- Issue
- 8
- Pages
- 2689-2696
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2052167215
- Cited by
- 124
- References
- 5
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An autoradiographic study of the distribution of binding sites for the novel α7‐selective nicotinic radioligand [3H]‐methyllycaconitine in the mouse brain. https://app.cochat.ai/papers/10.1046/j.1460-9568.1999.00685.x
- The paper
- Whiteaker, P., Davies, A. R. L., Marks, M. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., Collins, A. C., & Wonnacott, S. (1999). An autoradiographic study of the distribution of binding sites for the novel α7‐selective nicotinic radioligand [3H]‐methyllycaconitine in the mouse brain. European Journal of Neuroscience. https://doi.org/10.1046/j.1460-9568.1999.00685.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.